ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
AMPLIA THERAPEUTICS LTD
0.120
0.000
成交量:
55.37萬
成交額:
6.75萬
市值:
6,156.86萬
市盈率:
-7.32
高:
0.130
開:
0.120
低:
0.120
收:
0.120
52周最高:
0.275
52周最低:
0.100
股本:
5.13億
流通股本:
3.51億
量比:
0.87
換手率:
0.16%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.016
每股收益(LYR):
-0.016
淨資產收益率:
-25.48%
總資產收益率:
-16.29%
市淨率:
1.56
市盈率(LYR):
-7.32
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
Amplia與禮來簽署合作協議,評估Narmafotinib聯合禮來Kras G12c抑制劑Olomorasib用於非小細胞肺癌
美股速递
·
08/04
澳大利亞Amplia公司因與禮來公司合作開展抗癌藥物臨床試驗,股價升至4個月高點
路透中文
·
08/04
Amplia Therapeutics宣佈Warwick Tong將卸任董事會主席
投资观察
·
07/06
Amplia Therapeutics胰腺癌試驗再獲四例完全緩解 總體生存數據持續改善
美股速递
·
03/23
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/ATX.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATX.AU\",,,,,undefined,":{"symbol":"ATX.AU","market":"AU","secType":"STK","nameCN":"AMPLIA THERAPEUTICS LTD","latestPrice":0.12,"timestamp":1789452720000,"preClose":0.12,"halted":0,"volume":553722,"delay":0,"changeRate":0,"nameEN":"AMPLIA THERAPEUTICS LTD","floatShares":351321835,"shares":513071629,"eps":-0.0164,"marketStatus":"未開盤","change":0,"latestTime":"09-15 16:12:00 AEST","open":0.12,"high":0.13,"low":0.12,"amount":67467,"amplitude":0.083333,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0164,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.12,"openAndCloseTimeList":[[1789430400000,1789452000000]],"volumeRatio":0.8719545399669946,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ATX.AU","preClose":0.12,"auctionPrice":0.12,"auctionVolume":63336,"auction":3,"marketStatus":"盘后竞价","timestamp":1789452606450}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATX.AU\",,,,,undefined,":{"symbol":"ATX.AU","floatShares":351321835,"roa":"-16.29%","roe":"-25.48%","lyrEps":-0.0164,"volumeRatio":0.8719545399669946,"shares":513071629,"dividePrice":0,"high":0.13,"amplitude":0.083333,"preClose":0.12,"low":0.12,"week52Low":0.1,"pbRate":"1.56","psRate":"12.85","week52High":0.275,"institutionHeld":0,"latestPrice":0.12,"eps":-0.0164,"divideRate":0,"volume":553722,"delay":0,"ttmEps":-0.0164,"open":0.12,"prevYearClose":0.15,"prevWeekClose":0.12,"prevMonthClose":0.135,"prevQuarterClose":0.145,"fiveDayClose":0.13,"twentyDayClose":0.155,"sixtyDayClose":0.12,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-04-18","symbol":"ATX.AU","defaultRemindTime":1713398400000,"type":"split","dateTimestamp":1713362400000,"forFactor":971896,"toFactor":1000000,"ratio":0.971896}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1167934580","title":"Amplia與禮來簽署合作協議,評估Narmafotinib聯合禮來Kras G12c抑制劑Olomorasib用於非小細胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1167934580","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167934580?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 20:46","pubTimestamp":1785847602,"startTime":"0","endTime":"0","summary":"Amplia Therapeutics Ltd与礼来公司(Eli Lilly)达成了一项合作研究协议。根据协议,双方将评估Narmafotinib与礼来旗下Kras G12c抑制剂Olomorasib的联合用药方案,该组合旨在探索对非小细胞肺癌(NSCLC)的治疗潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","ATX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656583361","title":"澳大利亞Amplia公司因與禮來公司合作開展抗癌藥物臨床試驗,股價升至4個月高點","url":"https://stock-news.laohu8.com/highlight/detail?id=2656583361","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656583361?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 08:22","pubTimestamp":1785802943,"startTime":"0","endTime":"0","summary":"BUZZ-澳大利亚Amplia公司因与礼来公司合作开展抗癌药物临床试验,股价升至4个月高点8月4日-** 澳大利亚Amplia Therapeutics公司(ATX.AX)股价一度上涨37%至0.185澳元,创下自4月7日以来的最高水平** 该股创下自3月23日以来的最大盘中百分比涨幅** 这家制药公司与礼来公司((link)LLY.N)签署了一项临床试验合作及供应协议** 该公司表示,该协议旨在通过临床试验测试其实验性抗癌药物纳马福替尼与礼来公司正在研发的KRAS抑制剂奥洛莫拉西布的联合疗法** 包括当日涨幅在内,ATX今年累计上涨逾13%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL4S441010:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2746668974.SGD","LU2237443549.SGD","BK4533","LU1057294990.SGD","LU0203201768.USD","FHLC","LU2361045086.USD","LU2471134796.USD","XLV","LLY","LU0266013472.USD","LU1629891620.HKD","LU2462591350.SGD","SGXZ81514606.USD","BK4585","BK4516","PJP","LU0787776722.HKD","LU0683600562.USD","SG9999014914.USD","LU1069344957.HKD","LU1989771016.USD","SGXZ57979304.SGD","LU0122379950.USD","LU0354030511.USD","CURE","ELIS","BK4581","IE0001KFT4U8.USD","IE00B7KXQ091.USD","LU0158827948.USD","ILDR","IE00B4JS1V06.HKD","LU2168563687.JPY","IE00B1BXHZ80.USD","LU0225283273.USD","LU2168564495.EUR","LU0889565916.HKD","LU0820561909.HKD","LU2106854487.HKD","LU2237443622.USD","LU0256863811.USD","IE00BFSS7M15.SGD","LU2360106947.USD","LU2896262040.SGD","LLII","LU1145028129.USD","LU1551013342.USD","LU0058720904.USD","IE0004445239.USD","LU1974910355.USD","IE00BK4W5L77.USD","LU2028103732.USD","LU1720051017.SGD","IE00BJT1NW94.SGD","LU2089984988.USD","LU2471134879.HKD","MEDX","SG9999014898.SGD","LU0345770993.USD","SG9999015986.USD","IE0009355771.USD","BK7067","JDOC","IE0005OL40V9.USD","LU2089284900.SGD","LU0061475181.USD","LU1127390331.HKD","IE00BKDWB100.SGD","LU2023250330.USD","LU2602419157.SGD","ATX.AU","LU0109391861.USD","THNR","BK4007","IE00B4R5TH58.HKD","LU1720051108.HKD","LU0106261372.USD","LU2237443978.SGD","LU2417539215.USD","IE00BFSS8Q28.SGD","LU0417517546.SGD","LU0114720955.EUR","LU2746668461.USD","GB00BDT5M118.USD","LU1291159041.SGD","LU0689472784.USD","LU2108987350.USD","LU2112291526.USD","LU0210536198.USD","IE00B1XK9C88.USD","LU2168564222.USD","LU1366192091.USD","SG9999014880.SGD","LU0316494557.USD","IE0002141913.USD","IE00BJJMRY28.SGD","LU1712237335.SGD","LU0456855351.SGD","LU1868836757.USD","LU0203202063.USD","LU2756315664.SGD","LU0353189763.USD","LU2461242641.AUD","LU0109394709.USD","IE00BK4W5M84.HKD","SG9999015945.SGD","SG9999015978.USD","LU2211815571.USD","LLYZ","LU1232071149.USD","IE00B2B36J28.USD","LU1548497426.USD","LU1804176565.USD","LU1988902786.USD","HRTS","LU2468319806.SGD","LU1623119135.USD","LU2237443895.HKD","LLYX","BK4534","SG9999017495.SGD","LU0094547139.USD","LU0354030438.USD","LU0820562030.AUD","SG9999013999.USD","IE00BJJMRZ35.SGD","SG9999015952.SGD","LU2087625088.SGD","LU0823416689.USD","SG9999018865.SGD","LU2361044865.SGD","LU0882574055.USD","LU1323610961.USD","IE00BWXC8680.SGD","LU1280957306.USD","LU1983299246.USD","LU2552382132.HKD","SG9999001176.USD","LU2264538146.SGD","LU2552382215.SGD","LU0432979614.USD","LU2456880835.USD","LU0823434583.USD","LU1093756325.SGD","LU2552382058.USD","LU1023059063.AUD","SG9999018857.SGD","LU0158827781.USD","LU0323591593.USD","IE00BJJMRX11.SGD","LU1093756168.USD","AGNG","LU0174119429.USD","LU0385154629.USD","MEDI","LU2265009873.SGD","VHT","LU2237443465.HKD","LU0708995401.HKD","IE0004445015.USD","LU2324357040.USD","SGXZ99366536.SGD","LU0471298777.SGD","LU1267930730.SGD","IE00BKPKM429.USD","LU0256863902.USD","LU2491049909.HKD","LU2023250504.SGD","IXJ","LU1868836591.USD","LU0882574139.USD","LU2471134952.CNY","LU1064131342.USD","CANC","LU2271345857.HKD","LU2750360997.AUD","LU0820561818.USD","LU0079474960.USD","IE00B775H168.HKD","LU1868837136.USD","SGXZ51526630.SGD","LU0096364046.USD","LU0786609619.USD","RXL","LU2213496289.HKD","LU0353189680.USD","LU2491050071.SGD","LU2491050154.USD","MHIP","IE00BJLML261.HKD","IYH","LU0640476718.USD","LU2111349929.HKD","LU0823434740.USD","BK4588","IE00BFTCPJ56.SGD","LU0672654240.SGD","LU0238689110.USD","LU2462157665.USD","SG9999014906.USD","LU2168564065.EUR","LU0345770308.USD","LU2023251221.USD","LU1061106388.HKD","FTXH","LU0234572021.USD","LU1035775433.USD","LU2168564149.EUR","LU2089283258.USD","LU0289739699.SGD","LU0320765059.SGD","LU1814569148.SGD","LU2063271972.USD","SG9999001176.SGD","LU0006306889.USD","ELIL","GDOC","LU0097036916.USD","LU0133085943.USD","LU0320765992.SGD","LU1979441026.SGD","LU2237438978.USD","TRUH","LU2471134523.USD","LU2750360641.GBP","WDNA","LU0471298694.HKD","TMED","LU1868837300.USD","OZEM","LU1551013425.SGD","LU2361044949.HKD","LU2236285917.USD","BK4599","LU0964807845.USD","LU0198837287.USD","LU0943347566.SGD","LU1868836914.USD","PPH","LU1917777945.USD","LU2756315318.SGD","SGXZ31699556.SGD","LU0466842654.USD","IE00BN29S564.USD","LU2237443382.USD","IHE","LU2357305700.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149963822","title":"Amplia Therapeutics宣佈Warwick Tong將卸任董事會主席","url":"https://stock-news.laohu8.com/highlight/detail?id=1149963822","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149963822?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 15:18","pubTimestamp":1783322324,"startTime":"0","endTime":"0","summary":"6月30日 - Amplia Therapeutics Ltd宣布,Warwick Tong将从董事会主席一职上退休。公司已任命Jane Bell AM接任该职位,此项任命自2026年6月30日起生效。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113965610","title":"Amplia Therapeutics胰腺癌試驗再獲四例完全緩解 總體生存數據持續改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1113965610","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113965610?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 20:45","pubTimestamp":1774269918,"startTime":"0","endTime":"0","summary":"生物制药企业AmplIA THERAPEUTICS LTD最新临床数据显示,其针对胰腺癌的ACCENT试验取得突破性进展。该研究在原有成果基础上新增四例完全缓解病例,同时患者总体生存期呈现显著延长趋势。此次数据更新进一步验证了候选药物在晚期胰腺癌治疗领域的潜力,为后续研发提供重要临床依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","ATX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ATX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}